Improved iron status parameters may be a benefit of hormone replacement therapy

Journal of Women's Health and Gender-Based Medicine

Volumn 9, Issue 2, 2000, Pages 141-151

  Penckofer, Sue ^a   Schwertz, Dorie ^b  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; ESTRADIOL; ESTROGEN; FERRITIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IRON; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

AGE; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; ESTROGEN BLOOD LEVEL; FERRITIN BLOOD LEVEL; HEART INFARCTION; HORMONE SUBSTITUTION; HUMAN; IRON BINDING CAPACITY; IRON BLOOD LEVEL; LIPID BLOOD LEVEL; PHYSICAL ACTIVITY; POSTMENOPAUSE; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD;

DIET; ESTROGEN REPLACEMENT THERAPY; EXERCISE; FEMALE; FERRITINS; HUMANS; IRON; LIFE STYLE; MIDDLE AGED; QUESTIONNAIRES;

EID: 0034125387     PISSN: 15246094     EISSN: None     Source Type: Journal    
DOI: 10.1089/152460900318632     Document Type: Article

References (44)

1. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. JAMA 1995;273:199.
2. Sullivan J. The iron paradigm of ischemic heart disease. Am Heart J 1989;117:1177.
3. Penckofer S, Holm K, Schwertz D, Chandler P. The relationship of menopausal status and serum ferritin to cardiovascular risk. Women's Health Issues 1997;7:55.
4. Skikne B, Cook J. Serum ferritin in the evaluation of iron status. Lab Management 1981;19:31.
5. Baynes R. Assessment of iron status. Clin Biochem 1996;29:209.
6. Halliwell B. Free radicals, antioxidants and human disease: Curiosity, cause or consequence. Lancet 1994;344:721.
7. Salonen J, Nyyssonen K, Korpela H, Tuomilehto J, Seppanen R, Salonen R. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 1992;86:803.
8. Steinberg D, Parthasarathy S, Carew T, Khoo J, Witztum J. Beyond cholesterol: Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989;320:915.
9. Corti M, Gaziano M, Hennekens C. Iron status and risk of cardiovascular disease. Ann Epidemiol 1997;7:62.
10. deValk B, Marx JM. Iron, atherosclerosis, and ischemic heart disease. Arch Intern Med 1999;159:1542.
11. Meyers D. The iron hypothesis - Does iron cause atherosclerosis? Clin Cardiol 1996;19:925.
12. Wells MS, Awad WM. Iron and heme metabolism. In: Devlin T, ed. The textbook of biochemistry with clinical correlations. New York: Wiley-Liss, 1992:1001.
13. Yuan XM, Brunk UT. Iron and LDL-oxidation in atherogenesis. Acta Pathologica Microbiologica et immunologica Scandinavica 1998;106:825.
14. Fishbach F. A manual of laboratory and diagnostic tests, 4th ed. Philadelphia: JB Lippincott, 1992.
15. Kaseta J, Skafar D, Ram J, Jacober S, Sowers J. Cardiovascular disease in the diabetic woman. J Clin Endocrinol Metab 1999;84:1835.
16. Milman N, Kirchhoff M, Jorgensen T. Iron status markers, serum ferritin, and hemoglobin in 1359 Danish women in relation to menstruation, hormonal contraception, parity, and postmenopausal hormone treatment. Ann Hematol 1992;65:96.
17. Morrison HI, Semenciw RM, Mao Y, Wigle DT. Serum iron and risk of fatal acute myocardial infarction. Epidemiology 1994;5:243.
18. Magnusson M, Sigfusson N, Sigvaldason H, Johannesson G, Magnusson S, Thorgeirsson G. Low iron-binding capacity as a risk factor for myocardial infarction. Circulation 1994;89:102.
19. Cook J, Finch C, Smith N. Evaluation of the iron status of a population. Blood 1976;48:449.
20. Lauffer RB. Exercise as prevention: Do the health benefits derive in part from lower iron levels? Med Hypotheses 1991;35:103.
21. Fogelholm M, Jaakkola L, Lampisjarvi T. Effects of iron supplementation in female athletes with low serum ferritin concentration. Int J Sports Med 1992;13:158.
22. Naimark BJ, Ready AE, Sawatzky JA, et al. Serum ferritin and heart disease: The effect of moderate exercise on stored iron levels in postmenopausal women. Can J Cardiol 1996;12:1253.
23. Sullivan J. Iron and the sex difference in heart disease risk. Lancet 1981;1:1293.
24. Meyers D, Strickland D, Maloley P, Seburg J, Wilson J, McManus B. Possible association of a reduction in cardiovascular events with blood donation. Heart 1997;78:188.
25. Tuomainen T, Salonen R, Nyyssonen K, Salonen J. Cohort study of relation between donating blood and risk of myocardial infarction in 2682 men in eastern Finland. Br Med J 1997;314:793.
26. U.S. Congress, Office of Technology Assessment. The menopause, hormone therapy, and women's health, OTA-BP-BA-88. Washington, DC: U.S. Government Printing Office, 1992.
27. Guetta V, Panza J, Waclawiw M, Cannon R. Effect of combined 17β-estradiol and vitamin E on low-density lipoprotein oxidation in postmenopausal women. Am J Cardiol 1995;75:1274.
28. Dinneen SF, O'Mahony MS, O'Brien T, Cronin CC, Murray DM, O'Sullivan DJ. Serum ferritin in newly diagnosed and poorly controlled diabetes mellitus. Irish J Med Sci 1992;161:636.
29. Kaye TB, Guay AT, Simonson DC. Non-insulin dependent diabetes mellitus and elevated serum ferritin level. J Diabetes Complications 1993;7:246.
30. Cross C, Halliwell B, Borish E, et al. Oxygen radicals and human disease. Ann Intern Med 1987;107:526.
31. Brink P, Wood M. Advanced design in nursing research. Newbury Park, CA: Sage Publications, 1989.
32. Block G, Hartman AM, Dresser CM, Carroll MD, Gannon J, Gardner L. A data-based approach to diet questionnaire design and testing. Am J Epidemiol 1986;124:453.
33. Ainsworth BE, Jacobs DR, Leon AS. Validity and reliability of self-reported physical activity status: The Lipid Research Clinics questionnaire. Med Sci Sports Exerc 1993;25:92.
34. Briggs MH, Briggs M. Contraceptives and serum proteins. Br Med J 1970;3:521.
35. Burton JL. Effect of oral contraceptives on hemoglobin, packed-cell volume, serum iron, and total iron-binding capacity in healthy women. Lancet 1967;1:978.
36. Mardell M, Symmons C, Zilva J. A comparison of the effect of oral contraceptives, pregnancy and sex on iron metabolism. J Clin Endocrinol Metab 1969;29:1489.
37. Mardell M, Zilva J. Effect of oral contraceptives on the variations in serum iron during the menstrual cycle. Lancet 1967;2:1323.
38. Masse P, Roberge A. Long-term effect of low-dose combined steroid contraceptives on body iron status. Contraception 1992;46:243.
39. Jonsson J, Johannesson G, Sigfusson N, Magnusson B, Thjodleifsson B, Magnusson S. Prevalence of iron deficiency and iron overload in the adult Icelandic population. J Clin Epidemiol 1991;44:1289.
40. Manson JE, Colditz GA, Stampfer MJ, et al. A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med 1990;322:882.
41. Sperhoff L, Glass R, Kase N. Clinical gynecologic endocrinology and infertility, 6th ed. Baltimore: Williams & Wilkins, 1999.
42. American Heart Association. 1999 Heart and stroke statistical update. Dallas, TX: AHA, 1999.
43. Lorrain J, Lalumiere G, Filion A, Caron P. Use of transdermal estrogen gel in postmenopausal women. Menopause Management 1999;8:11.
44. Pryor W. Oxidative stress status measurements in humans and their use in clinical trials. In: Yagi K, ed. Active oxygens, lipid peroxides and antioxidants. Boca Raton: CRC Press, 1993:117.